Belgians still hope for deal on EU patent language this year
This article was originally published in RAJ Devices
Executive Summary
The Belgian presidency of the EU Council of Ministers believes that a compromise can still be reached this year on the translation issues that are holding up agreement on the future EU patent system, even though there is still strong opposition to the current proposal from at least two member states. The proposal needs the unanimous support of all 27 member states if it is to come into effect.
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.